Femoral Neck Locking Plate Vs Multiple Cannulated Cancellous Screws in Treatment of Femoral Neck Fractures in Young Adults: Randomized Controlled Clinical Trial Study
Launched by ESLAM MOHAMED AHMED · Dec 7, 2023
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is comparing two different surgical methods for treating femoral neck fractures in young adults, which are breaks in the top part of the thigh bone near the hip joint. The trial will specifically look at the effectiveness of a locking plate versus multiple screws in helping these fractures heal properly. Femoral neck fractures can happen due to high-energy accidents, and it's important to treat them right away to avoid complications like poor blood supply to the hip, which can lead to further problems.
To be eligible for this trial, participants should be between 20 and 55 years old and have a single traumatic femoral neck fracture. They should have been able to walk independently before the injury. Unfortunately, individuals with certain conditions, like open fractures or other injuries in the same area, cannot participate. If you join this study, you will receive one of the two surgical treatments and be monitored for your recovery. This research aims to find out which method works better for young adults with these types of fractures.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • patients (20-55) years
- • having unilateral traumatic femoral neck fracture
- • idependent walker before trauma without any aids
- Exclusion Criteria:
- • open fracture
- • pathological fracture
- • preexisting deformity
- • other pelvic or ipsilateral femoral injuries
- • renal impairment or were on high dose steroids
About Eslam Mohamed Ahmed
Eslam Mohamed Ahmed is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes. With a robust background in clinical methodologies and regulatory compliance, Eslam leads innovative studies aimed at evaluating the safety and efficacy of novel therapeutic interventions. His expertise encompasses various therapeutic areas, ensuring a thorough understanding of both the scientific and ethical dimensions of clinical research. Eslam's collaborative approach fosters strong partnerships with research institutions, healthcare professionals, and regulatory bodies, driving the successful execution of trials that contribute to the advancement of healthcare solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Sohag, , Egypt
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported